Reviews - 4dep mentioned but not cited (5)
- Subversion of cytokine networks by virally encoded decoy receptors. Epperson ML, Lee CA, Fremont DH. Immunol. Rev. 250 199-215 (2012)
- Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses. Krumm B, Xiang Y, Deng J. Protein Sci. 23 526-538 (2014)
- Structural Basis for LAR-RPTP-Mediated Synaptogenesis. Won SY, Kim HM. Mol. Cells 41 622-630 (2018)
- Structural Basis of IL-1 Family Cytokine Signaling. Fields JK, Günther S, Sundberg EJ. Front Immunol 10 1412 (2019)
- The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Luís JP, Simões CJV, Brito RMM. Int J Mol Sci 23 1731 (2022)
Articles - 4dep mentioned but not cited (28)
- Structure of the activating IL-1 receptor signaling complex. Thomas C, Bazan JF, Garcia KC. Nat. Struct. Mol. Biol. 19 455-457 (2012)
- Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties. Issafras H, Corbin JA, Goldfine ID, Roell MK. J. Pharmacol. Exp. Ther. 348 202-215 (2014)
- Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces. Luchini A, Espina V, Liotta LA. Nat Commun 5 4413 (2014)
- The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. Acuner Ozbabacan SE, Gursoy A, Nussinov R, Keskin O. PLoS Comput. Biol. 10 e1003470 (2014)
- Mechanisms of splicing-dependent trans-synaptic adhesion by PTPδ-IL1RAPL1/IL-1RAcP for synaptic differentiation. Yamagata A, Yoshida T, Sato Y, Goto-Ito S, Uemura T, Maeda A, Shiroshima T, Iwasawa-Okamoto S, Mori H, Mishina M, Fukai S. Nat Commun 6 6926 (2015)
- Critical role of IL-1α in IL-1β-induced inflammatory responses: cooperation with NF-κBp65 in transcriptional regulation. Singh AK, Fechtner S, Chourasia M, Sicalo J, Ahmed S. FASEB J 33 2526-2536 (2019)
- The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β. Rondeau JM, Ramage P, Zurini M, Gram H. MAbs 7 1151-1160 (2015)
- Structural and Functional Attributes of the Interleukin-36 Receptor. Yi G, Ybe JA, Saha SS, Caviness G, Raymond E, Ganesan R, Mbow ML, Kao CC. J. Biol. Chem. 291 16597-16609 (2016)
- Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method. Yang CY. PLoS ONE 10 e0118671 (2015)
- Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Guven-Maiorov E, Acuner-Ozbabacan SE, Keskin O, Gursoy A, Nussinov R. Cancers (Basel) 6 663-683 (2014)
- Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling. Ren X, Gelinas AD, von Carlowitz I, Janjic N, Pyle AM. Nat Commun 8 810 (2017)
- Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain. Yang CY, Delproposto J, Chinnaswamy K, Brown WC, Wang S, Stuckey JA, Wang X. PLoS ONE 11 e0146522 (2016)
- The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease. Smith SA, Samokhin AO, Alfadi M, Murphy EC, Rhodes D, Holcombe WML, Kiss-Toth E, Storey RF, Yee SP, Francis SE, Qwarnstrom EE. JACC Basic Transl Sci 2 398-414 (2017)
- Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation. Fuglestad B, Kerstetter NE, Bédard S, Wand AJ. ACS Chem Biol 14 2224-2232 (2019)
- Network Pharmacology and Molecular Docking-Based Strategy to Investigate the Multitarget Mechanisms of Shenqi Yizhi Granule on Alzheimer's Disease. Wang L, Xu X, Wang Z, Chen Q, Wei X, Xue J, Zhang Z, Wang M, Li Y, Zhang J, Wei D. Evid Based Complement Alternat Med 2022 8032036 (2022)
- Structure and function of chicken interleukin-1 beta mutants: uncoupling of receptor binding and in vivo biological activity. Chen WT, Huang WY, Chen T, Salawu EO, Wang D, Lee YZ, Chang YY, Yang LW, Sue SC, Wang X, Yin HS. Sci Rep 6 27729 (2016)
- X-ray crystal structure localizes the mechanism of inhibition of an IL-36R antagonist monoclonal antibody to interaction with Ig1 and Ig2 extra cellular domains. Larson ET, Brennan DL, Hickey ER, Ganesan R, Kroe-Barrett R, Farrow NA. Protein Sci 29 1679-1686 (2020)
- Bio-guided isolation of potential anti-inflammatory constituents of some endophytes isolated from the leaves of ground cherry (Physalis pruinosa L.) via ex-vivo and in-silico studies. Mahana A, Hammoda HM, Saad MMG, Radwan MM, ElSohly MA, Ghareeb DA, Harraz FM, Shawky E. BMC Complement Med Ther 23 103 (2023)
- Characterization and Validation of Arg286 Residue of IL-1RAcP as a Potential Drug Target for Osteoarthritis. Dailing A, Mitchell K, Vuong N, Lee KH, Joshi R, Espina V, Haymond Still A, Gottschalk CJ, Brown AM, Paige M, Liotta LA, Luchini A. Front Chem 8 601477 (2020)
- Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors. Yang CY. Sci Rep 10 7399 (2020)
- Conformational Dynamics of the Soluble and Membrane-Bound Forms of Interleukin-1 Receptor Type-1: Insights into Linker Flexibility and Domain Orientation. Luís JP, Mata AI, Simões CJV, Brito RMM. Int J Mol Sci 23 2599 (2022)
- Data Mining, Network Pharmacology, and Molecular Docking Explore the Effects of Core Traditional Chinese Medicine Prescriptions in Patients with Rectal Cancer and Qi and Blood Deficiency Syndrome. Ma S, Zheng L, Zheng L, Bian X. Evid Based Complement Alternat Med 2021 1353674 (2021)
- Decoding the Mechanism of CheReCunJin Formula in Treating Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking. Xu X, Wang L, Chen Q, Wang Z, Pan X, Peng X, Wang M, Wei D, Li Y, Wu B. Evid Based Complement Alternat Med 2022 1193846 (2022)
- Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. Hommel U, Hurth K, Rondeau JM, Vulpetti A, Ostermeier D, Boettcher A, Brady JP, Hediger M, Lehmann S, Koch E, Blechschmidt A, Yamamoto R, Tundo Dottorello V, Haenni-Holzinger S, Kaiser C, Lehr P, Lingel A, Mureddu L, Schleberger C, Blank J, Ramage P, Freuler F, Eder J, Bornancin F. Nat Commun 14 5497 (2023)
- Functional Relevance of Interleukin-1 Receptor Inter-domain Flexibility for Cytokine Binding and Signaling. Ge J, Remesh SG, Hammel M, Pan S, Mahan AD, Wang S, Wang X. Structure 27 1296-1307.e5 (2019)
- Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy. Nisar M, Paracha RZ, Gul A, Arshad I, Ejaz S, Murad D, Khan S, Mustansar Z. Front Oncol 12 832277 (2022)
- Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis via p38 Pathway. Tan Q, Duan L, Huang Q, Chen W, Yang Z, Chen J, Jin Y. J Inflamm Res 14 6491-6509 (2021)
- Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor. Fields JK, Kihn K, Birkedal GS, Klontz EH, Sjöström K, Günther S, Beadenkopf R, Forsberg G, Liberg D, Snyder GA, Deredge D, Sundberg EJ. Front Immunol 12 779100 (2021)
Reviews citing this publication (16)
- Molecular basis of NF-κB signaling. Napetschnig J, Wu H. Annu Rev Biophys 42 443-468 (2013)
- TLR agonists: our best frenemy in cancer immunotherapy. Kaczanowska S, Joseph AM, Davila E. J. Leukoc. Biol. 93 847-863 (2013)
- The interleukin-1 receptor family. Boraschi D, Tagliabue A. Semin. Immunol. 25 394-407 (2013)
- Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains. Ve T, Williams SJ, Kobe B. Apoptosis 20 250-261 (2015)
- Structural biology of innate immunity. Yin Q, Fu TM, Li J, Wu H. Annu. Rev. Immunol. 33 393-416 (2015)
- Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Ferrao R, Li J, Bergamin E, Wu H. Sci Signal 5 re3 (2012)
- Special aspects of interleukin-33 and the IL-33 receptor complex. Martin MU. Semin. Immunol. 25 449-457 (2013)
- Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Felix J, Savvides SN. Nat. Rev. Immunol. 17 112-129 (2017)
- Multifarious determinants of cytokine receptor signaling specificity. Moraga I, Spangler J, Mendoza JL, Garcia KC. Adv. Immunol. 121 1-39 (2014)
- Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders. Bahia MS, Kaur M, Silakari P, Silakari O. Cell. Signal. 27 1039-1055 (2015)
- The family of the interleukin-1 receptors. Boraschi D, Italiani P, Weil S, Martin MU. Immunol. Rev. 281 197-232 (2018)
- Function and regulation of IL-1α in inflammatory diseases and cancer. Malik A, Kanneganti TD. Immunol. Rev. 281 124-137 (2018)
- Interleukin-36: Structure, Signaling and Function. Zhou L, Todorovic V. Adv Exp Med Biol 21 191-210 (2021)
- Targeting IL-1β in the Treatment of Atherosclerosis. Mai W, Liao Y. Front Immunol 11 589654 (2020)
- The Role of Toll-Like Receptors in Oncotherapy. Liu C, Han C, Liu J. Oncol Res 27 965-978 (2019)
- Interleukin-1 as Innate Mediator of T Cell Immunity. Van Den Eeckhout B, Tavernier J, Gerlo S. Front Immunol 11 621931 (2020)
Articles citing this publication (27)
- IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, Lotz-Havla AS, Gersting SW, Cho SX, Lao JC, Ellisdon AM, Rotter B, Azam T, Mangan NE, Rossello FJ, Whisstock JC, Bufler P, Garlanda C, Mantovani A, Dinarello CA, Nold MF, Nold MF. Nat. Immunol. 16 354-365 (2015)
- Structural insights into the interaction of IL-33 with its receptors. Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, Wang S, Wang X. Proc. Natl. Acad. Sci. U.S.A. 110 14918-14923 (2013)
- Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus. Prieto GA, Snigdha S, Baglietto-Vargas D, Smith ED, Berchtold NC, Tong L, Ajami D, LaFerla FM, Rebek J, Cotman CW. Proc. Natl. Acad. Sci. U.S.A. 112 E5078-87 (2015)
- IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. Ferrao R, Zhou H, Shan Y, Liu Q, Li Q, Shaw DE, Li X, Wu H. Mol. Cell 55 891-903 (2014)
- Molecular determinants of agonist and antagonist signaling through the IL-36 receptor. Günther S, Sundberg EJ. J Immunol 193 921-930 (2014)
- One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β. Blech M, Peter D, Fischer P, Bauer MM, Hafner M, Zeeb M, Nar H. J. Mol. Biol. 425 94-111 (2013)
- The structural basis for receptor recognition of human interleukin-18. Tsutsumi N, Kimura T, Arita K, Ariyoshi M, Ohnishi H, Yamamoto T, Zuo X, Maenaka K, Park EY, Kondo N, Shirakawa M, Tochio H, Kato Z. Nat Commun 5 5340 (2014)
- Design of a superior cytokine antagonist for topical ophthalmic use. Hou J, Townson SA, Kovalchin JT, Masci A, Kiner O, Shu Y, King BM, Schirmer E, Golden K, Thomas C, Garcia KC, Zarbis-Papastoitsis G, Furfine ES, Barnes TM. Proc. Natl. Acad. Sci. U.S.A. 110 3913-3918 (2013)
- Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. Ganesan R, Raymond EL, Mennerich D, Woska JR, Caviness G, Grimaldi C, Ahlberg J, Perez R, Roberts S, Yang D, Jerath K, Truncali K, Frego L, Sepulveda E, Gupta P, Brown SE, Howell MD, Canada KA, Kroe-Barrett R, Fine JS, Singh S, Mbow ML. MAbs 9 1143-1154 (2017)
- Transcriptome analysis of hen preadipocytes treated with an adipogenic cocktail (DMIOA) with or without 20(S)-hydroxylcholesterol. Regassa A, Kim WK. BMC Genomics 16 91 (2015)
- Understanding the folding-function tradeoff in proteins. Gosavi S. PLoS ONE 8 e61222 (2013)
- Association of the Precursor of Interleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis. Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z. J. Clin. Lab. Anal. 30 831-837 (2016)
- Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout. Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Crespo-Golmar A, López-Fagúndez M, Pazos-Pérez A, Gualillo O, Belén Bravo S, Gómez Bahamonde R. Br J Pharmacol 179 270-286 (2022)
- Structural basis for the specific recognition of IL-18 by its alpha receptor. Wei H, Wang D, Qian Y, Liu X, Fan S, Yin HS, Wang X. FEBS Lett. 588 3838-3843 (2014)
- IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor. Günther S, Deredge D, Bowers AL, Luchini A, Bonsor DA, Beadenkopf R, Liotta L, Wintrode PL, Sundberg EJ. Immunity 47 510-523.e4 (2017)
- Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. Van Den Eeckhout B, Van Hoecke L, Burg E, Van Lint S, Peelman F, Kley N, Uzé G, Saelens X, Tavernier J, Gerlo S. NPJ Vaccines 5 64 (2020)
- An innate interaction between IL-18 and the propeptide that inactivates its precursor form. Tsutsumi N, Yokota A, Kimura T, Kato Z, Fukao T, Shirakawa M, Ohnishi H, Tochio H. Sci Rep 9 6160 (2019)
- Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding. Yuan X, Chinnaswamy K, Stuckey JA, Yang CY. J Phys Chem B 126 2394-2406 (2022)
- Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease. Galozzi P, Baggio C, Bindoli S, Oliviero F, Sfriso P. Front Pharmacol 9 1074 (2018)
- Identification of critical regions within the TIR domain of IL-1 receptor type I. Radons J, Falk W, Dove S. Int. J. Biochem. Cell Biol. 68 15-20 (2015)
- MyD88 Costimulation in Donor CD8+ T Cells Enhances the Graft-versus-Tumor Effect in Murine Hematopoietic Cell Transplantation. Ciavattone NG, Wu L, O'Neill R, Qiu J, Davila E, Cao X. J Immunol 206 892-903 (2021)
- Optimization of IL-1RA structure to achieve a smaller protein with a higher affinity to its receptor. Nouri Barkestani M, Naserian S, Khoddam F, Shamdani S, Bambai B. Sci Rep 12 7483 (2022)
- Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α. DeVoti JA, Israr M, Lam F, Papayannakos C, Frank DK, Kamdar DP, Pereira LM, Abramson A, Steinberg BM, Bonagura VR. Front Immunol 13 1011772 (2022)
- Site-Resolved and Quantitative Characterization of Very Weak Protein-Ligand Interactions. Fuglestad B, Kerstetter NE, Wand AJ. ACS Chem Biol 14 1398-1402 (2019)
- Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis. Todorović V, Su Z, Putman CB, Kakavas SJ, Salte KM, McDonald HA, Wetter JB, Paulsboe SE, Sun Q, Gerstein CE, Medina L, Sielaff B, Sadhukhan R, Stockmann H, Richardson PL, Qiu W, Argiriadi MA, Henry RF, Herold JM, Shotwell JB, McGaraughty SP, Honore P, Gopalakrishnan SM, Sun CC, Scott VE. Sci Rep 9 9089 (2019)
- Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. Van Den Eeckhout B, Van Hoecke L, Burg E, Van Lint S, Peelman F, Kley N, Uzé G, Saelens X, Tavernier J, Gerlo S. NPJ Vaccines 5 64 (2020)
- Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling. Zhou J, Xiao Y, Ren Y, Ge J, Wang X. iScience 25 104508 (2022)